Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and Finland [PDF]
Anders Rønneholt‐Frederiksen +8 more
openalex +1 more source
Treatment of atypical uraemic syndrome in the era of eculizumab [PDF]
Véronique Frémeaux‐Bacchi
openalex +1 more source
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study. [PDF]
Iori AP +35 more
europepmc +1 more source
Early access program for danicopan (ALXN2040) as add-on treatment to eculizumab or ravulizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH): Preliminary data from the Italian real-world survey. [PDF]
Elisabetta Metafuni +16 more
openalex +1 more source
Complement C5 Inhibitor Ameliorates a Case of Dysferlinopathy. [PDF]
Kang S +9 more
europepmc +1 more source
Eculizumab inhibits thrombotic microangiopathy and improves renal function in pediatric patients with atypical hemolytic uremic syndrome [PDF]
Al-Akash, Samhar I +15 more
core
Effect of early initation of Eculizumab in patients with aHUS on renal outcomes: a pooled analysis [PDF]
Ardissimo, Gianluigi +5 more
core
Case 25-2014: A man with ulcerative colitis and bloody diarrhea. [PDF]
Mullish, BH
core +1 more source

